Molecular Phenotypes of Sex- and Age-Specific Differences Relating to Outcome in Patients With Ebola Virus Disease
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiag305 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Xiaofeng Dong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infection, Veterinary and Ecological Science, Faculty of Health and Life Science, University of Liverpool, UK. Hauptthemen laut MEDLINE: Hemorrhagic Fever, Ebola, Ebolavirus. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FDA HHS, Pandemic Institute, Food and Drug Administration.
Abstract (Originalsprache)
Background
Ebola virus causes a severe, potentially fatal disease with the outcome likely related to viral and host factors. There is a clear correlation between viral load and outcome (survival/death), and inflammatory and other cellular pathways are differentially activated in the acute stage between patients who survive and those who die. Age and sex may influence the course of Ebola virus disease with potential differences at the molecular level.
Methods
To investigate whether there were age- and/or sex-specific differences in patients with Ebola virus disease, previously published data from an RNA sequencing analysis of the blood transcriptome in patients from the 2013–2016 West African outbreak were stratified according to age and sex. This was correlated with the outcome of infection.
Results
Similar to the previously published data, immune responses were downregulated during the acute phase in hospitalized survivors as compared with hospitalized fatal cases, regardless of the sex of the patient. However, aspects of the blood transcriptome/host response differed between females and males and certain age groups at the transcriptomic level. Genes associated with the lymphocyte differentiation pathway decreased in expression level with age in hospitalized fatal cases. However, this was the opposite in hospitalized survivors.
Conclusions
From a medical countermeasure perspective, the work indicated that selection of animal models should consider age and sex, depending on the research question, and cellular pathways were identified that could be chemotherapeutically enhanced to promote survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Infection, Veterinary and Ecological Science, Faculty of Health and Life Science, University of Liverpool, UK.
- European Plotkin Institute for Vaccinology, Universite Libré de Bruxelles (ULB), Belgium.
- Office Regulatory and Emerging Science, Office of the Chief Scientist, US Food and Drug Administration, Silver Spring, Maryland, USA.
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
- The Pandemic Institute, Liverpool, UK.
- Wellcome Centre for Human Genetics.
ORCID-Profile: Xiaofeng Dong, Natasha Y Rickett, Piet Maes, Tracy MacGill, Julian A Hiscox
Förderung
- FDA HHS
- Pandemic Institute
- Food and Drug Administration
Zitieren
APA
Dong, X., Rickett, N. Y., Maes, P., Orr, R., MacGill, T., Myers, T., Fletcher, T., Carroll, M. W., & Hiscox, J. A. (2026). Molecular Phenotypes of Sex- and Age-Specific Differences Relating to Outcome in Patients With Ebola Virus Disease. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag305
Vancouver
Dong X, Rickett NY, Maes P, Orr R, MacGill T, Myers T, et al. Molecular Phenotypes of Sex- and Age-Specific Differences Relating to Outcome in Patients With Ebola Virus Disease. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag305
BibTeX
@article{Dong2026,
author = {Dong, Xiaofeng and Rickett, Natasha Y and Maes, Piet and Orr, Robert and MacGill, Tracy and Myers, Todd and Fletcher, Tom and Carroll, Miles W and Hiscox, Julian A},
title = {Molecular Phenotypes of Sex- and Age-Specific Differences Relating to Outcome in Patients With Ebola Virus Disease},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiag305}
}
EUVIMED